Funding
Series D · Biotech

ClearNote Health raises $52M Series D

ClearNote Health raised $52 million in Series D financing announced in May.

Updated Oct 16, 2026By RoundOS Funding desk

Mattias Westman, Sandy Weill and Stephen Quake are among its backers. The company develops blood-based early-detection tests for pancreatic and ovarian cancers.

Funding history

Series D · This round$52M

Sources

  1. ClearNote Healthprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related